Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Surgery

• Publication date

  2005-04-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/J.AMJSURG.2005.01.011PMID 15820454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Linezolid versus Vancomycin on Length of Hospital Stay in Patients with Complicated Skin and Soft Tissue Infections Caused by Known or Suspected Methicillin-Resistant Staphylococci: Results from a Randomized Clinical Trial

  2003cited by this paper
• Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).

  2003cited by this paper
• Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

  2002cited by this paper
• Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

  2002cited by this paper
• [Pathogen resistance and other risk factors in the frequency of lower limb amputations in patients with the diabetic foot syndrome].

  2002cited by this paper
• The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria

  1998cited by this paper
• Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

  1994cited by this paper
• A history of the Infectious Diseases Society of America.

  1988cited by this paper
• Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.

  1982cited by this paper

• Toxin inhibition: Examining tetracyclines, clindamycin, and linezolid.

  2024cites this paper
• Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Insufficient Representation of Patients With Obesity in Randomized Controlled Trials Evaluating the Efficacy and Safety of Antimicrobials for Treatment of Skin and Skin Structure Infections: A Scoping Review

  2023cites this paper
• Efficacy and Safety of Different Antibiotic Therapies for Bone and Joint Infections: A Network Meta-analysis of Randomized Controlled Trials.

  2023cites this paper
• Impact of Empiric Linezolid for Necrotizing Soft Tissue Infections on Duration of Methicillin-Resistant Staphylococcus aureus-Active Therapy

  2022cites this paper
• Efficacy and safety of optional parenteral antimicrobial therapy for complicated skin and soft tissue infections: A systematic review and Bayesian network meta-analysis

  2022cites this paper
• Postoperative management of patients with thoracic aorta diseases from the position of a cardiologist

  2022cites this paper
• Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

  2021cites this paper
• Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis

  2021cites this paper
• An optimized method for the detection and spatial distribution of aminoglycoside and vancomycin antibiotics in tissue sections by mass spectrometry imaging.

  2021cites this paper
• Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection

  2020cites this paper
• Gaultheria longibracteolata, an alternative source of wintergreen oil.

  2020cites this paper
• Staphylococcal infections and infertility: mechanisms and management

  2020cites this paper
• [Modern problems of modelling and treatment of soft tissues abscesses].

  2020cites this paper
• Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

  2019cites this paper
• Pathogenic Microbial Genetic Diversity with Reference to Health

  2019cites this paper
• Optimizing skin and skin structure infection outcomes: considerations of cost of care

  2018cites this paper
• Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis

  2017cites this paper
• Evaluation of the Clinical Course of Methicillin-resistant Staphylococcus Aureus Infections in Consideration of the Efficacy of Linezolid

  2017cites this paper
• [Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].

  2017cites this paper
• Efficacy and safety of linezolid compared with other treatments for skin and soft tissue infections: a meta-analysis

  2017cites this paper
• Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA

  2017cites this paper
• Comparison of protein-chip array analysis and traditional ELISAs for biomarker detection of diabetic limb arterial stenosis

  2017cites this paper
• The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections

  2017cites this paper
• Linezolid: a promising option in the treatment of Gram-positives

  2017cites this paper
• High frequency of MRSA in surgical site infections and elevated vancomycin MIC

  2017cites this paper
• The effect of Rhazya stricta aqueous leaves extract on MRSA genotypes in Jeddah province

  2016cites this paper
• Linezolid versus vancomycin for skin and soft tissue infections.

  2016cites this paper
• New therapeutic options for skin and soft tissue infections

  2016cites this paper
• MRSA and Complicated Skin and Soft Tissue Infections

  2016cites this paper
• Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.

  2016cites this paper
• Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study

  2016cites this paper
• Hot topics in the diagnosis and management of skin and soft-tissue infections.

  2016cites this paper
• Economic Features of Antibiotic Resistance: The Case of Methicillin-Resistant Staphylococcus aureus

  2015cites this paper
• Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection

  2015cites this paper
• Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis

  2015cites this paper
• Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection?

  2015cites this paper
• Diabetic Foot Infection

  2015cites this paper
• Prevalence and Antimicrobial Susceptibility of Methicillin-resistant Staphylococcus aureus in Pregnant Women and Their Newborns in Las Vegas , Nevada Authors

  2015cites this paper
• Treatment of gram - positive infections in critically ill patients

  2014cites this paper
• Treatment of infections due to resistant Staphylococcus aureus.

  2014cites this paper
• European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

  2014influential citation
• Linezolid versus vancomycin for skin and soft tissue infections.

  2014cites this paper
• Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?

  2014cites this paper
• A Comparative Study between Ceftobiprole and Vancomycin in treating Skin and Soft Tissue Infections (SSTIs) du e to Methicillin Resistant staphylococcus aureus in Mice

  2014cites this paper
• Novel antibiotic treatment for skin and soft tissue infection

  2014cites this paper
• Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China.

  2014cites this paper
• Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals

  2014cites this paper
• The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections

  2013cites this paper
• Linezolid versus vancomycin for skin and soft tissue infections.

  2013cites this paper
• Efficacy of Ceftobiprole in Treating of Osteomyelitis Due to Methicillin Resistant Staphylococcus aureusin Rabbits

  2013cites this paper
• Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.

  2013cites this paper
• Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.

  2013cites this paper
• Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections

  2013cites this paper
• Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin

  2013cites this paper
• Antimicrobial Activity of Hippurate Nanocomposite and Its Cytotoxicity Effect in Combination with Cytarabine against HL-60

  2013cites this paper
• Linezolid in the treatment of orthopaedic bone and joint infections-a systematic literature review

  2013cites this paper
• M an ag em en t Linezolid in the treatment of orthopaedic bone and joint infections — a systematic literature review

  2013cites this paper
• Drug Use Evaluation of Arbekacin

  2012cites this paper
• A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection.

  2012cites this paper
• [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].

  2012cites this paper
• Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus

  2012influential citation
• Daptomicina en el contexto de la resistencia a los antimicrobianos en bacterias grampositivas

  2012cites this paper
• Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.

  2012cites this paper
• Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.

  2012cites this paper
• Diabetic foot infections: the role of microbiology and antibiotic treatment.

  2012cites this paper
• Infectious skin diseases: a review and needs assessment.

  2012cites this paper
• Cost comparison of linezolid versus vancomycin for treatment of complicated skin and skin-structure infection caused by methicillin-resistant Staphylococcus aureus in Quebec.

  2012cites this paper
• Cost–effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections

  2012cites this paper
• Linezolid and Vancomycin in Treatment of Lower-Extremity Complicated Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus in Patients with and without Vascular Disease

  2012cites this paper
• In Vivo Bioluminescence Imaging To Evaluate Systemic and Topical Antibiotics against Community-Acquired Methicillin-Resistant Staphylococcus aureus-Infected Skin Wounds in Mice

  2012cites this paper
• Optimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care

  2011cites this paper
• Treatment of MRSA soft tissue infections: an overview.

  2011cites this paper
• Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

  2010cites this paper
• Complicated skin and soft tissue infection.

  2010cites this paper
• Prosthetic joint infections: single versus combination therapy.

  2010cites this paper
• Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin

  2010cites this paper
• Infectious complications of arteriovenous ePTFE grafts for hemodialysis.

  2010cites this paper
• Resistant pathogen-associated skin and skin-structure infections: antibiotic options

  2010cites this paper
• A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

  2010cites this paper
• Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis

  2010cites this paper
• Emerging drugs for complicated skin and skin-structure infections

  2010cites this paper
• Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

  2010cites this paper
• Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.

  2010cites this paper
• Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.

  2010cites this paper
• Prävention, Diagnose, Therapie und Nachsorge der Sepsis

  2010cites this paper
• Comparative Effectiveness of Linezolid and Vancomycin among a National Cohort of Patients Infected with Methicillin-Resistant Staphylococcus aureus

  2010cites this paper
• Compassionate Use of Linezolid for Adult Taiwanese Patients with Bone and Joint Infections

  2010cites this paper
• Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis

  2010cites this paper
• Present and Emerging Therapies for the Treatment of Drug-resistant Infections: Focus on Linezolid

  2010cites this paper
• Antimicrobial Resistance Among Epidemiologically Important Gram-Positive Bacteria

  2010cites this paper
• Prevalence and Antimicrobial Susceptibility of Methicillin-resistant Staphylococcus aureus in Pregnant Women and Their Newborns in Las Vegas, Nevada

  2010cites this paper
• Clinical Experience with Linezolid at a Large Academic Medical Center: A Case Series and Review of the Literature

  2010cites this paper
• Prävention, Diagnose, Therapie und Nachsorge der Sepsis

  2010cites this paper
• Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections

  2010cites this paper
• Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.

  2009cites this paper
• Update on Cutaneous Manifestations of Infectious Diseases

  2009cites this paper
• New antibiotics: optimal use in current clinical practice.

  2009cites this paper
• Cost‐effectiveness analysis of linezolid vs. vancomycin in treating methicillin‐resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model

  2009cites this paper
• inezolid versus vancomycin for the treatment of Gram-positive bacterial nfections : meta-analysis of randomised controlled trials

  2009cites this paper